Request Deal Involvement
Sequoia China led the $150m Series B round in VISEN Pharmaceuticals.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Principals
target
VISEN PHARMACEUTICALS
bidder
ORBIMED PE
bidder
SHERPA HEALTHCARE PARTNERS
bidder
CORMORANT ASSET MANAGEMENT
bidder
HBM HEALTHCARE INVESTMENTS
bidder
PIVOTAL BIOVENTURE PARTNERS LLC
bidder
LOGOS CAPITAL
bidder
CDG GROUP LLC
bidder
ASCENDIS PHARMA AS
bidder
VIVO CAPITAL LLC
bidder
SOFINNOVA PARTNERS
bidder
HONGSHAN (EX-SEQUOIA CAPITAL CHINA)
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite